Pfizer record breaking 9 month sprint to Covid-19 vaccine: A timeline MD Bureau22 Nov 2020 10:00 AM ISTNew York: Pfizer announced Friday it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent efficacy in...
Covid-19: Saudi Arabia commits over Rs 3708 crore to vaccine development Ruchika Sharma22 Nov 2020 9:00 AM ISTRiyadh: The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine...
Russia resumes Covid vaccine trial after pause Ruchika Sharma21 Nov 2020 11:51 AM ISTMoscow: Russia has resumed the vaccination of new volunteers in its trial for its flagship Covid-19 Sputnik V vaccine after a short pause, staff at...
Covishield to be priced at Rs 1000 for 2 necessary doses for public, says Serum CEO Ruchika Sharma20 Nov 2020 12:30 PM ISTPoonawalla said the Oxford vaccine is affordable, safe and stored at a temperature of two to eight degrees Celsius, which is an ideal temperature for...
AstraZeneca, Oxford COVID vaccine shows promise, trial results by December Ruchika Sharma20 Nov 2020 12:00 PM ISTLondon: AstraZeneca and Oxford University's potential Covid-19 vaccine produced a strong immune response in older adults, data published on Thursday...
Sinovac COVID-19 vaccine CoronaVac induces quick immune response: study Ruchika Sharma20 Nov 2020 9:00 AM ISTSingapore/Beijing: Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced...
Pfizer to seek emergency use authorization for Covid vaccine with 95 percent efficacy Ruchika Sharma19 Nov 2020 2:30 PM ISTNew Delhi: Pfizer Inc said on Wednesday that final results from the late-stage trial of its Covid-19 vaccine show it was 95% effective, adding it had...
Covaxin phase 3 trial to begin on November 20, Minister Anil Vij offers to be 1st volunteer Ruchika Sharma19 Nov 2020 12:19 PM ISTChandigarh: Haryana Health Minister Anil Vij on Wednesday said the third phase of trial of Covaxin, a potential vaccine against COVID-19, will begin...
India in dialogue with Moderna, other biotech firms over progress in COVID vaccine development: Sources Ruchika Sharma18 Nov 2020 11:25 AM ISTNew Delhi: India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials of its coronavirus vaccine candidate,...
After Pfizer, Moderna Covid vaccine shows 94 percent efficacy MD Bureau17 Nov 2020 4:00 PM ISTBoth Moderna and Pfizer, BioNTech use the 'mRNA' technology which means the vaccine is not embedded with the virus itself and therefore no risk of...
Biological E begins phase I, II human trials of Covid vaccine Ruchika Sharma17 Nov 2020 1:55 PM ISTHyderabad: Biological E. Limited, a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies Corporation , a US-based vaccine focused...
Bharat Biotech Covaxin enters phase 3 trials Ruchika Sharma17 Nov 2020 1:00 PM ISTCovaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of...
